Genomics BioSci (Taiwan) Price Prediction
| 4195 Stock | TWD 24.80 0.25 1.02% |
Momentum 58
Buy Extended
Oversold | Overbought |
Using Genomics BioSci hype-based prediction, you can estimate the value of Genomics BioSci Tech from the perspective of Genomics BioSci response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Genomics BioSci to buy its stock at a price that has no basis in reality. In that case, they are not buying Genomics because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Genomics BioSci after-hype prediction price | TWD 24.8 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Genomics |
Genomics BioSci After-Hype Price Prediction Density Analysis
As far as predicting the price of Genomics BioSci at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Genomics BioSci or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Genomics BioSci, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Genomics BioSci Estimiated After-Hype Price Volatility
In the context of predicting Genomics BioSci's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Genomics BioSci's historical news coverage. Genomics BioSci's after-hype downside and upside margins for the prediction period are 22.85 and 26.75, respectively. We have considered Genomics BioSci's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Genomics BioSci is very steady at this time. Analysis and calculation of next after-hype price of Genomics BioSci Tech is based on 3 months time horizon.
Genomics BioSci Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Genomics BioSci is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Genomics BioSci backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Genomics BioSci, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.15 | 1.95 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
24.80 | 24.80 | 0.00 |
|
Genomics BioSci Hype Timeline
Genomics BioSci Tech is presently traded for 24.80on Taiwan OTC Exchange of Taiwan. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Genomics is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at -0.15%. %. The volatility of related hype on Genomics BioSci is about 0.0%, with the expected price after the next announcement by competition of 24.80. The company last dividend was issued on the 16th of July 2020. Genomics BioSci Tech had 1000:1020 split on the 5th of August 2023. Assuming the 90 days trading horizon the next anticipated press release will be in 5 to 10 days. Check out Genomics BioSci Basic Forecasting Models to cross-verify your projections.Genomics BioSci Related Hype Analysis
Having access to credible news sources related to Genomics BioSci's direct competition is more important than ever and may enhance your ability to predict Genomics BioSci's future price movements. Getting to know how Genomics BioSci's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Genomics BioSci may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 6676 | Sunny Pharmtech | 0.00 | 0 per month | 2.09 | 0.07 | 5.26 | (4.47) | 22.10 | |
| 1762 | Chunghwa Chemical Synthesis | 0.00 | 0 per month | 0.73 | (0.04) | 1.63 | (1.18) | 9.07 | |
| 6709 | Advagene Biopharma Co | 0.00 | 0 per month | 0.00 | (0.16) | 3.20 | (3.71) | 16.90 | |
| 6846 | Greenyn Biotechnology Co | 0.00 | 0 per month | 0.91 | (0.06) | 1.91 | (1.71) | 5.90 | |
| 6872 | NaviFUS Corp | 0.00 | 0 per month | 1.05 | (0.06) | 2.32 | (1.91) | 6.77 | |
| 6564 | Enimmune corporation | 0.00 | 0 per month | 1.34 | 0.01 | 4.78 | (2.33) | 9.31 | |
| 4724 | Meribank Biotech Co | 0.00 | 0 per month | 0.00 | (0.05) | 5.26 | (3.72) | 14.75 | |
| 6934 | 6934 | 0.00 | 0 per month | 3.04 | 0.28 | 18.06 | (8.04) | 45.51 | |
| 4171 | GeneReach Biotechnology | 0.00 | 0 per month | 2.64 | 0.08 | 9.89 | (5.17) | 19.35 | |
| 4168 | GlycoNex | 0.00 | 0 per month | 1.92 | 0.08 | 7.23 | (2.70) | 18.02 |
Genomics BioSci Additional Predictive Modules
Most predictive techniques to examine Genomics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Genomics using various technical indicators. When you analyze Genomics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Genomics BioSci Predictive Indicators
The successful prediction of Genomics BioSci stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Genomics BioSci Tech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Genomics BioSci based on analysis of Genomics BioSci hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Genomics BioSci's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Genomics BioSci's related companies.
Pair Trading with Genomics BioSci
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Genomics BioSci position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genomics BioSci will appreciate offsetting losses from the drop in the long position's value.Moving against Genomics Stock
| 0.54 | 6547 | Medigen Vaccine Biologics | PairCorr |
| 0.54 | 4162 | PharmaEngine | PairCorr |
| 0.46 | 6712 | Ever Supreme Bio | PairCorr |
| 0.43 | 4174 | OBI Pharma Split | PairCorr |
| 0.41 | 2851 | Central Reinsurance Corp | PairCorr |
The ability to find closely correlated positions to Genomics BioSci could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genomics BioSci when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genomics BioSci - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genomics BioSci Tech to buy it.
The correlation of Genomics BioSci is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Genomics BioSci moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Genomics BioSci Tech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Genomics BioSci can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Genomics Stock Analysis
When running Genomics BioSci's price analysis, check to measure Genomics BioSci's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genomics BioSci is operating at the current time. Most of Genomics BioSci's value examination focuses on studying past and present price action to predict the probability of Genomics BioSci's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genomics BioSci's price. Additionally, you may evaluate how the addition of Genomics BioSci to your portfolios can decrease your overall portfolio volatility.